Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Systems Chronotherapeutics.

Ballesta A, Innominato PF, Dallmann R, Rand DA, Lévi FA.

Pharmacol Rev. 2017 Apr;69(2):161-199. doi: 10.1124/pr.116.013441. Review.

2.

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M; Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International).

Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.

PMID:
26578731
3.

Phase locking and multiple oscillating attractors for the coupled mammalian clock and cell cycle.

Feillet C, Krusche P, Tamanini F, Janssens RC, Downey MJ, Martin P, Teboul M, Saito S, Lévi FA, Bretschneider T, van der Horst GT, Delaunay F, Rand DA.

Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9828-33. doi: 10.1073/pnas.1320474111. Epub 2014 Jun 23.

4.

The circadian timing system in clinical oncology.

Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Lévi FA.

Ann Med. 2014 Jun;46(4):191-207. doi: 10.3109/07853890.2014.916990. Review.

PMID:
24915535
5.

Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy.

Roche VP, Mohamad-Djafari A, Innominato PF, Karaboué A, Gorbach A, Lévi FA.

Chronobiol Int. 2014 Apr;31(3):409-20. doi: 10.3109/07420528.2013.864301. Epub 2014 Jan 7.

6.

Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.

Innominato PF, Giacchetti S, Bjarnason GA, Focan C, Garufi C, Coudert B, Iacobelli S, Tampellini M, Durando X, Mormont MC, Waterhouse J, Lévi FA.

Int J Cancer. 2012 Dec 1;131(11):2684-92. doi: 10.1002/ijc.27574. Epub 2012 Jul 3.

7.

Chronotherapy and the molecular clock: Clinical implications in oncology.

Innominato PF, Lévi FA, Bjarnason GA.

Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):979-1001. doi: 10.1016/j.addr.2010.06.002. Epub 2010 Jun 23. Review.

PMID:
20600409
8.

Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: implications for innovative therapeutic approaches.

Innominato PF, Mormont MC, Rich TA, Waterhouse J, Lévi FA, Bjarnason GA.

Integr Cancer Ther. 2009 Dec;8(4):361-70. Review.

PMID:
20050374
9.

The circadian timing system: a coordinator of life processes: chronobiological investigations. Implications for the rhythmic delivery of cancer therapeutics.

Lévi FA.

IEEE Eng Med Biol Mag. 2008 Jan-Feb;27(1):17-9. doi: 10.1109/MEMB.2007.907361. Review. No abstract available.

PMID:
18270045
10.

Relationship between circadian rhythm of vinorelbine toxicity and efficacy in P388-bearing mice.

Filipski E, Amat S, Lemaigre G, Vincenti M, Breillout F, Lévi FA.

J Pharmacol Exp Ther. 1999 Apr;289(1):231-5.

11.

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.

Lévi FA, Zidani R, Vannetzel JM, Perpoint B, Focan C, Faggiuolo R, Chollet P, Garufi C, Itzhaki M, Dogliotti L, et al.

J Natl Cancer Inst. 1994 Nov 2;86(21):1608-17.

PMID:
7932825
12.

Circadian and estral changes in the hypothalamic prostaglandin e content and [h]prostaglandin e binding in female rats.

Bommelaer-Bayet MC, Wisner A, Renard CA, Levi FA, Dray F.

J Neuroendocrinol. 1990 Apr 1;2(2):193-9. doi: 10.1111/j.1365-2826.1990.tb00850.x.

PMID:
19210383
13.
14.

Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men.

Lévi FA, Canon C, Touitou Y, Sulon J, Mechkouri M, Ponsart ED, Touboul JP, Vannetzel JM, Mowzowicz I, Reinberg A, et al.

Clin Exp Immunol. 1988 Feb;71(2):329-35.

15.

Eicosanoids in relation with LHRH secretion.

Wisner-Provost A, Gerozissis K, Bommelaer MC, Renard CA, Rougeot C, Levi FA, Dray F.

Adv Prostaglandin Thromboxane Leukot Res. 1986;16:235-40. No abstract available.

PMID:
2880485
16.

Circadian changes in anticoagulant effect of heparin infused at a constant rate.

Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, De Bonadona JF, Reinberg A, Queneau PM.

Br Med J (Clin Res Ed). 1985 Feb 2;290(6465):341-4.

17.

Circadian and/or circahemidian rhythms in nine lymphocyte-related variables from peripheral blood of healthy subjects.

Levi FA, Canon C, Blum JP, Mechkouri M, Reinberg A, Mathe G.

J Immunol. 1985 Jan;134(1):217-22.

PMID:
3855259
18.

A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.

Levi FA, Blum JP, Lemaigre G, Bourut C, Reinberg A, Mathé G.

Cancer Res. 1984 Jun;44(6):2660-7.

19.

Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration.

Levi FA, Hrushesky WJ, Halberg F, Langevin TR, Haus E, Kennedy BJ.

Eur J Cancer Clin Oncol. 1982 May;18(5):471-7.

PMID:
6889525
20.

Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.

Levi FA, Hrushesky WJ, Blomquist CH, Lakatua DJ, Haus E, Halberg F, Kennedy BJ.

Cancer Res. 1982 Mar;42(3):950-5.

21.

Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats.

Hrushesky WJ, Levi FA, Halberg F, Kennedy BJ.

Cancer Res. 1982 Mar;42(3):945-9.

22.

[Notes on the International Symposium for the Measurement of Ionizing Radiations].

LEVI FA.

Riv Biol. 1958 Jul-Sep;50(3):305-10. Italian. No abstract available.

PMID:
13615157
23.

[Thermostat for use in microscopy].

LEVI FA.

Boll Soc Ital Biol Sper. 1954 Jul;30(7):772-4. Italian. No abstract available.

PMID:
14351445
24.

[Experimental apparatus for research on the effects of ultrasonics].

LEVI FA.

Boll Soc Ital Biol Sper. 1954 Jul;30(7):769-72. Italian. No abstract available.

PMID:
14351444
25.

[Some observations on hemolysis produced by ultrasounds].

GIOLITTI G, LEVI FA.

Boll Soc Ital Biol Sper. 1954 Jul;30(7):767-9. Italian. No abstract available.

PMID:
14351443
26.

[Inhibition of alkaline phosphatase by ultrasonics].

VANTAGGI COZZARI L, LEVI FA.

Boll Soc Ital Biol Sper. 1953 Sep-Nov;29(9-10-11):1723-4. Undetermined Language. No abstract available.

PMID:
13140688
27.

[Inactivation of hyaluronidase by ultrasound].

SANTAMARIA L, CASTELLANI A, LEVI FA.

Boll Soc Ital Biol Sper. 1950 Jun;26(6):924-7. Undetermined Language. No abstract available.

PMID:
14801258

Supplemental Content

Support Center